What is Shield Therapeutics plc (STX.L)?

Shield Therapeutics plc (STX.L) is a stock in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. View full analysis on Stocks360.

Shield Therapeutics plc (STX.L)

Stock analysis · LSE · Healthcare · Drug Manufacturers - Specialty & Generic

Market Cap

N/A

PE (TTM)

N/A

EPS (TTM)

N/A

Dividend Yield

N/A

Beta

1.73

Day Range

N/A

52-wk Range

N/A

Avg Volume

N/A

Volume

N/A

Shield Therapeutics plc (STX.L) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Earnings

Most Recent

Apr 24, 2025

EPS $-0.01 vs est. $-0.01

Beat by $0.00

Proprietary Signals

Signal snapshot temporarily unavailable.

About Shield Therapeutics plc

Shield Therapeutics plc, a commercial stage specialty pharmaceutical company, focuses on development and commercialization of clinical-stage pharmaceuticals to treat unmet medical needs. Its lead product is Accrufer/Feraccru, a non-salt based oral therapy for adults to treat the iron deficiency with or without anemia. Shield Therapeutics plc was incorporated in 2008 and is based in Gateshead, the United Kingdom.